The Europe Cephalosporin Drugs Market would witness market growth of 2.94% CAGR during the forecast period (2019–2025).

Cephalosporin Drugs is a bactericidal, wide-spectrum, -lactam antibiotic initially extracted from the Acremonium fungus that is used to treat bacterial diseases such as pneumonia, skin diseases, tonsillitis, otitis media, bronchitis, gonorrhea, and others. It is similar to penicillin and is, therefore, used as an option to penicillin-allergic patients.

Developing extremely effective and secure Cephalosporin Drugs, growing mergers and corporate acquisitions to manufacturing these drugs are likely to create growth opportunities for the market for Cephalosporin Drugs in the coming years. On the other hand, low R&D investment and rigid public policies on these medicines hamper the market growth.

Based on Generation, the market is segmented into First-Generation Cephalosporin, Second-Generation Cephalosporin, Third-Generation Cephalosporin, Fourth-Generation Cephalosporin, and Fifth-Generation Cephalosporin. Based on Application, the market is segmented into Respiratory Tract Infection, Skin Infection, Ear Infection, Sexually Transmitted Infection and Others. Based on Route of Administration, the market is segmented into Injections and Oral Drugs. Based on Type, the market is segmented into Branded and Generic. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.

Scope of the Study
Market Segmentation:
By Generation

  • First-Generation Cephalosporin
  • Second-Generation Cephalosporin
  • Third-Generation Cephalosporin
  • Fourth-Generation Cephalosporin
  • Fifth-Generation Cephalosporin


By Application

  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Sexually Transmitted Infection
  • Others


By Route of Administration

  • Injections
  • Oral Drugs


By Type

  • Branded
  • Generic


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • ABBOTT Laboratories
  • Teva Pharmaceuticals Industries Ltd.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Baxter International, Inc.
  • BRISTOL-MYERS SQUIBB COMPANY
  • Novartis AG


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free